Combination Therapy Could Provide New Treatment Option For Ovarian Cancer

May 5, 2017 4:05 pm

Researchers have been trying to understand why up to 85 percent of women experience recurrence of high-grade serous ovarian cancer — the most common subtype of ovarian cancer — after standard treatment with the chemotherapy drug carboplatin.

Preclinical research from … Read more